New Key Statistics Module, Z-Score and F-Score
WBO:MRNA Key Ratios
Market Cap € M | 27,926.50 |
Enterprise Value € M | 21,454.85 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.66 |
Price/Sales | 6.20 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) € M | 4,612.00 |
EPS (TTM) € | -14.34 |
Beneish M-Score | -3.56 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -468.30 |
EV-to-EBIT | -5.56 |
EV-to-EBITDA | -6.34 |
PEG | -- |
Shares Outstanding M | 384.40 |
Net Margin (%) | -117.62 |
Operating Margin % | -92.92 |
Pre-tax Margin (%) | -86.85 |
Quick Ratio | 3.92 |
Current Ratio | 4.09 |
ROA % (ttm) | -31.83 |
ROE % (ttm) | -42.65 |
ROIC % (ttm) | -64.09 |
Dividend Yield % | -- |
Altman Z-Score | 5.68 |
WBO:MRNA Number of Guru Trades
WBO:MRNA Volume of Guru Trades
Gurus Latest Trades with WBO:MRNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
WBO:MRNA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data